Yoko Azusawa

Advances in Allogeneic Cancer Cell Therapy and Future Perspectives on “Off-the-Shelf” T Cell Therapy Using iPSC Technology and Gene Editing

H. Nakauchi, Y. Hamano, M. Ando, 2022, Cells.

SCLC-J1, a novel small cell lung cancer cell line

Y. Mitsuishi, N. Komatsu, F. Takahashi, 2021, Biochemistry and biophysics reports.

Sarcoma-like appearance but pathologic Hodgkin lymphoma

N. Komatsu, Tomonori Ochiai, M. Ando, 2021, International Journal of Hematology.

Persistent immune thrombocytopaenic purpura associated with SARS‐CoV‐2 infection

N. Komatsu, Y. Tabe, Tomonori Ochiai, 2021, EJHaem.

Trigenic ADH5/ALDH2/ADGRV1 mutations in myelodysplasia with Usher syndrome

N. Komatsu, Y. Kishita, H. Eguchi, 2021, Heliyon.

Establishment of ganglioside GD2-expressing extranodal NK/T cell lymphoma cell line with scRNA-seq analysis.

M. Ando, Midori Ishii, Tokuko Toyota, 2023, Experimental hematology.

l-asparaginase monotherapy as an encouraging approach towards acute fulminant chronic active Epstein-Barr virus infection.

Y. Hamano, Tadaaki Inano, T. Takaku, 2024, British journal of haematology.

iPSC-derived hypoimmunogenic tissue resident memory T cells mediate robust anti-tumor activity against cervical cancer

Kyomi J. Igarashi, Y. Terao, M. Ando, 2023, Cell reports. Medicine.